New Bespoke service for small and emerging Pharma and Biotech companies

A new, tailor-made service for small and emerging Pharma and Biotech companies has just been launched by specialist scientific consulting organization, G&L Scientific.

Under the name Bespoke, this niche service will provide fully-integrated Regulatory and Quality support shepherding products through development and on to market.

Based and founded on many years of extensive practical experience with more than 2,500 consultants in over 100 countries, the team at G&L has a thorough understanding of the unique needs and demands of small and emerging companies and the challenges they face when seeking a suitable and appropriate service partner.

At the official launch, CEO of G&L Scientific, Mr Stephen Loughrey, said: “I am proud and excited to introduce you to our new service, Bespoke. We have identified a real need within the industry for a one-stop, tailor-made service that can shepherd any product through all stages of development right through to getting it to market.

“Our clients will be accompanied every step of the way by our specially chosen team of experts, hand-picked for each piece of work depending on individual requirements. They will have unfettered 24/7 access to their assigned Bespoke Engagement Lead as well as individual members of their dedicated Bespoke Team who will provide the appropriate expertise based on client need.

“We understand the unique needs and demands of small and emerging companies. Bespoke is about being more responsive, more nimble and more flexible through matching the right experts to individual client need. Our teams are excited at the prospect of building relationships with clients and seeing projects come to fruition, from concept initiation, early Non-Clinical and Clinical Strategy development, right through to seeing tangible products come to life through Manufacturing and Process Development, to Initial Filing, Post-Approval Maintenance and ROW Submissions.”

Stephen continued: “Bespoke has been developed with client benefits in mind. The concept will prove more cost-effective to the client as each project will be handled by the one set of experts. The ease of access to our experts at any stage also ensures the client gets the attention and service they deserve.”

The Bespoke website at www.bespokeconsultingservice.com/ highlights more of the benefits of this new service and has an online form to schedule a free introductory consultation with a Bespoke advisor.

ENDS

Further information

• G&L Scientific was founded by industry veterans, Peter Griffin and Stephen Loughrey, following the sale of their former company, Pharmalink Consulting, in 2014.
• Since then, G&L has experienced rapid growth, expanding into every major geography to become one of the most admired scientific consulting organizations.
• With more than 2,500 consultants in over 100 countries, the key to G&L’s success is a straightforward, transparent approach; experience of unrivalled depth; and the recruitment and development of brilliant people. Indeed, the level of repeat business and ongoing long-term assignments is testament to the quality of service G&L provides.
• The new Bespoke Division is being led by Richard Edmunds, Vice President, Regulatory Affairs for North American clients, and Dr Ivan Fisher, Vice President, Regulatory Affairs for all EU clients.

Contact details
For more details contact Tony Sheridan, Email: tsheridan@gandlscientific.com

Source: RealWire